Want to see IN:PRIMO full AI Analyst Report?
Top Page
Primo Chemicals Limited
(PRIMO)
Select Model
Select Model
Rating:65Neutral
Price Target:
₹23.00
▼(-2.99% Downside)
Action:Reiterated
Date:07/31/26
The score is primarily supported by stronger FY2026 fundamentals (rapid revenue growth, improved net profitability, better leverage, and higher free cash flow) and a constructive price trend above major moving averages. These positives are tempered by a demanding valuation (P/E ~35) and weakening operating margins versus the prior year, which increases execution risk if cost pressures persist.
Positive Factors
Strong Revenue Acceleration
The sharp FY2026 revenue increase indicates stronger business activity and improved scale. If sustained, this growth can expand the earnings base and support better fixed-cost absorption, although future performance will depend on maintaining demand and converting growth into profitable sales.
Negative Factors
Declining Operating Margins
Lower EBIT and EBITDA margins show that rapid revenue growth is not fully translating into operating profitability. If cost pressure or pricing constraints persist, earnings quality and the durability of recent profit improvement could remain limited.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Acceleration
The sharp FY2026 revenue increase indicates stronger business activity and improved scale. If sustained, this growth can expand the earnings base and support better fixed-cost absorption, although future performance will depend on maintaining demand and converting growth into profitable sales.
Read all positive factors
Primo Chemicals Limited (PRIMO) vs. iShares MSCI India ETF (INDA)
Market Cap
₹5.23B
Dividend YieldN/A
Average Volume (3M)114.88K
Price to Earnings (P/E)32.6
Beta (1Y)0.65
Revenue Growth-2.70%
EPS Growth-15.50%
CountryIN
Employees365
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)0.15
Shares Outstanding242,343,220
10 Day Avg. Volume11,926
30 Day Avg. Volume114,881
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.09
Price to Sales (P/S)0.79
P/FCF Ratio13.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Primo Chemicals Limited Business Overview & Revenue Model
Company Description
Headquartered in Chandigarh, India, Primo Chemicals Limited, established in 1975, is actively involved in the production and distribution of various chemical compounds across the country. The company's extensive product line encompasses industrial...
Primo Chemicals Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
74
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 2.90B | 5.62B | 5.56B |
| Gross Profit | 1.07B | 1.05B | 995.93M |
| EBITDA | 481.37M | 682.87M | 833.64M |
| Net Income | 37.51M | 153.71M | 35.60M |
Balance Sheet | |||
| Total Assets | 7.34B | 6.92B | 7.41B |
| Cash, Cash Equivalents and Short-Term Investments | 138.79M | 107.08M | 82.46M |
| Total Debt | 1.62B | 1.31B | 1.69B |
| Total Liabilities | 3.35B | 2.86B | 3.50B |
| Stockholders Equity | 3.99B | 4.06B | 3.91B |
Cash Flow | |||
| Free Cash Flow | 164.50M | 327.29M | 242.82M |
| Operating Cash Flow | 504.21M | 587.45M | 644.34M |
| Investing Cash Flow | -303.76M | -194.76M | -446.55M |
| Financing Cash Flow | -194.10M | -384.17M | -90.29M |
Primo Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹8.52B | 15.42 | ― | ― | 1.41% | 946.38% | |
67 Neutral | ₹8.78B | 10.86 | ― | 0.38% | 13.23% | 21.18% | |
65 Neutral | ₹5.23B | 32.64 | ― | ― | -2.70% | -15.50% | |
59 Neutral | ₹7.00B | 18.78 | ― | 0.83% | 49.58% | 43.22% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | ₹6.54B | 32.34 | ― | 0.34% | -77.13% | ― | |
44 Neutral | ₹2.45B | -23.80 | ― | 0.42% | -39.30% | -700.73% |
* General Sector Average
IN:PRIMO
Primo Chemicals Limited
21.23
-4.44
-17.30%
IN:DIAMINESQ
Diamines & Chemicals Ltd.
242.65
-122.35
-33.52%
IN:DMCC
DMCC Speciality Chemicals Limited
300.90
-7.29
-2.36%
IN:INDOAMIN
Indo Amines Limited
120.85
-23.64
-16.36%
IN:UNIENTER
Uniphos Enterprises Limited
94.00
-53.07
-36.08%
IN:VALIANTORG
Valiant Organics Limited
296.40
-41.35
-12.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.